SIGLEC‑1 expression correlates with disease activity in patients with lupus erythematosus during type I interferon blockade by anifrolumab.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/siglec-1-tracks-response-anifrolumab-lupus-erythematosus-2026a10004aq?src=rss
Author :
Publish date : 2026-02-11 16:05:00
Copyright for syndicated content belongs to the linked Source.